KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Free Cash Flow (2016 - 2026)

Pfizer has reported Free Cash Flow over the past 18 years, most recently at $2.2 billion for Q1 2026.

  • Quarterly Free Cash Flow rose 23.04% to $2.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.5 billion through Mar 2026, up 180.23% year-over-year, with the annual reading at $9.1 billion for FY2025, 7.73% down from the prior year.
  • Free Cash Flow was $2.2 billion for Q1 2026 at Pfizer, down from $4.5 billion in the prior quarter.
  • Over five years, Free Cash Flow peaked at $18.5 billion in Q4 2022 and troughed at -$2.4 billion in Q2 2024.
  • The 5-year median for Free Cash Flow is $2.6 billion (2023), against an average of $3.3 billion.
  • Year-over-year, Free Cash Flow plummeted 128.6% in 2023 and then surged 428.77% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $18.5 billion in 2022, then tumbled by 77.26% to $4.2 billion in 2023, then dropped by 3.93% to $4.0 billion in 2024, then rose by 11.71% to $4.5 billion in 2025, then tumbled by 51.61% to $2.2 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Free Cash Flow are $2.2 billion (Q1 2026), $4.5 billion (Q4 2025), and $4.0 billion (Q3 2025).